메뉴 건너뛰기




Volumn 31, Issue 3, 2015, Pages e68-e70

A case report of orbital inflammatory syndrome secondary to ipilimumab

Author keywords

[No Author keywords available]

Indexed keywords

IPILIMUMAB; LEVOTHYROXINE; PHENYLEPHRINE; PREDNISONE; STEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

EID: 84899782496     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0000000000000081     Document Type: Article
Times cited : (28)

References (10)
  • 1
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • Hodi FS, O'Day SJ, McDermott DF, Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010 363 711 23
    • (2010) N Engl J Med , vol.363 , pp. 711-723
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3
  • 2
    • 84856014065 scopus 로고    scopus 로고
    • Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer
    • Graziani G, Tentori L, Navarra P, Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer. Pharmacol Res 2012 65 9 22
    • (2012) Pharmacol Res , vol.65 , pp. 9-22
    • Graziani, G.1    Tentori, L.2    Navarra, P.3
  • 3
    • 84859393995 scopus 로고    scopus 로고
    • CTLA-4 blockade with ipilimumab: Long-term follow-up of 177 patients with metastatic melanoma
    • Prieto PA, Yang JC, Sherry RM, CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma. Clin Cancer Res 2012 18 2039 47
    • (2012) Clin Cancer Res , vol.18 , pp. 2039-2047
    • Prieto, P.A.1    Yang, J.C.2    Sherry, R.M.3
  • 4
    • 75249100054 scopus 로고    scopus 로고
    • Ipilimumab monotherapy in patients with pretreated advanced melanoma: A randomised, double-blind, multicentre, phase 2, dose-ranging study
    • Wolchok JD, Neyns B, Linette G, Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol 2010 11 155 64
    • (2010) Lancet Oncol , vol.11 , pp. 155-164
    • Wolchok, J.D.1    Neyns, B.2    Linette, G.3
  • 5
    • 79953653271 scopus 로고    scopus 로고
    • Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma
    • Kähler KC, Hauschild A, Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma. J Dtsch Dermatol Ges 2011 9 277 86
    • (2011) J Dtsch Dermatol Ges , vol.9 , pp. 277-286
    • Kähler, K.C.1    Hauschild, A.2
  • 6
    • 84864052441 scopus 로고    scopus 로고
    • Management of immune-related adverse events and kinetics of response with ipilimumab
    • Weber JS, Kähler KC, Hauschild A, Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 2012 30 2691 7
    • (2012) J Clin Oncol , vol.30 , pp. 2691-2697
    • Weber, J.S.1    Kähler, K.C.2    Hauschild, A.3
  • 7
    • 78751559991 scopus 로고    scopus 로고
    • Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy
    • Min L, Vaidya A, Becker C, Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy. Eur J Endocrinol 2011 164 303 7
    • (2011) Eur J Endocrinol , vol.164 , pp. 303-307
    • Min, L.1    Vaidya, A.2    Becker, C.3
  • 8
    • 79960559927 scopus 로고    scopus 로고
    • Drug-induced Graves disease from CTLA-4 receptor suppression
    • Borodic G, Hinkle DM, Cia Y, Drug-induced Graves disease from CTLA-4 receptor suppression. Ophthal Plast Reconstr Surg 2011 27 e87 8
    • (2011) Ophthal Plast Reconstr Surg , vol.27 , pp. e87-e88
    • Borodic, G.1    Hinkle, D.M.2    Cia, Y.3
  • 10
    • 84872339660 scopus 로고    scopus 로고
    • The price of tumor control: An analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
    • Voskens CJ, Goldinger SM, Loquai C, The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS One 2013 8 e53745
    • (2013) PLoS One , vol.8 , pp. e53745
    • Voskens, C.J.1    Goldinger, S.M.2    Loquai, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.